Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06220864
SNV1521 in Participants with Advanced Solid Tumors
200 Enrollment(s)
9 Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Solid Tumor
RECRUITING
NCT06210776
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
800 Enrollment(s)
54 Study location(s)
OBSERVATIONAL (None)
HER2-positive Breast Cancer


HER2-low Breast Cancer


Breast Cancer


Advanced Cancer
RECRUITING
NCT06172127
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
165 Enrollment(s)
23 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
RECRUITING
NCT06100874
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
40 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Her 2 Positive Breast Cancer


Breast Cancer Female


Breast Cancer Metastatic
RECRUITING
NCT05982678
Basket Study for Oligo-metastatic Breast Cancer
72 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
TERMINATED
NCT05954143
Trial of BDC-1001 +/- Pertuzumab in Subjects with HER2-Positive Metastatic Breast Cancer
11 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer


HER2-positive Breast Cancer
RECRUITING
NCT05950945
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
250 Enrollment(s)
70 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT05869591
DOAC in Patients with Child a or B Liver Cirrhosis
40 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Liver Cirrhosis